Microbix Biosystems Inc. (MBX) - Total Assets
Based on the latest financial reports, Microbix Biosystems Inc. (MBX) holds total assets worth CA$35.37 Million CAD (≈ $25.58 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Microbix Biosystems Inc. (MBX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Microbix Biosystems Inc. - Total Assets Trend (1997–2025)
This chart illustrates how Microbix Biosystems Inc.'s total assets have evolved over time, based on quarterly financial data. Check Microbix Biosystems Inc. earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Microbix Biosystems Inc. - Asset Composition Analysis
Current Asset Composition (September 2025)
Microbix Biosystems Inc.'s total assets of CA$35.37 Million consist of 63.0% current assets and 37.0% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 32.4% |
| Accounts Receivable | CA$1.61 Million | 4.3% |
| Inventory | CA$9.20 Million | 24.6% |
| Property, Plant & Equipment | CA$10.10 Million | 27.0% |
| Intangible Assets | CA$3.73 Million | 10.0% |
| Goodwill | CA$0.00 | 0.0% |
Asset Composition Trend (1997–2025)
This chart illustrates how Microbix Biosystems Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Microbix Biosystems Inc. market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Microbix Biosystems Inc.'s current assets represent 63.0% of total assets in 2025, a decrease from 87.9% in 1997.
- Cash Position: Cash and equivalents constituted 32.4% of total assets in 2025, down from 67.0% in 1997.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, an increase from 0.0% in 1997.
- Asset Diversification: The largest asset category is property, plant & equipment at 27.0% of total assets.
Microbix Biosystems Inc. Competitors by Total Assets
Key competitors of Microbix Biosystems Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $8.59 Billion |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
USA | $763.95 Million |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
|
China | CN¥4.48 Billion |
|
Novavax Inc
NASDAQ:NVAX
|
USA | $1.04 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF2.64 Billion |
Microbix Biosystems Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.35 | 9.36 | 4.02 |
| Quick Ratio | 2.91 | 6.37 | 2.87 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$17.93 Million | CA$23.17 Million | CA$12.62 Million |
Microbix Biosystems Inc. - Advanced Valuation Insights
This section examines the relationship between Microbix Biosystems Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.53 |
| Latest Market Cap to Assets Ratio | 0.80 |
| Asset Growth Rate (YoY) | -1.8% |
| Total Assets | CA$37.41 Million |
| Market Capitalization | $29.84 Million USD |
Valuation Analysis
Below Book Valuation: The market values Microbix Biosystems Inc.'s assets below their book value (0.80x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Microbix Biosystems Inc.'s assets decreased by 1.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Microbix Biosystems Inc. (1997–2025)
The table below shows the annual total assets of Microbix Biosystems Inc. from 1997 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | CA$37.41 Million ≈ $27.06 Million |
-1.80% |
| 2024-09-30 | CA$38.10 Million ≈ $27.56 Million |
+6.85% |
| 2023-09-30 | CA$35.65 Million ≈ $25.79 Million |
+7.57% |
| 2022-09-30 | CA$33.15 Million ≈ $23.98 Million |
+14.97% |
| 2021-09-30 | CA$28.83 Million ≈ $20.85 Million |
+84.83% |
| 2020-09-30 | CA$15.60 Million ≈ $11.28 Million |
-20.54% |
| 2019-09-30 | CA$19.63 Million ≈ $14.20 Million |
+1.65% |
| 2018-09-30 | CA$19.31 Million ≈ $13.97 Million |
-26.96% |
| 2017-09-30 | CA$26.44 Million ≈ $19.12 Million |
+4.71% |
| 2016-09-30 | CA$25.25 Million ≈ $18.26 Million |
+7.22% |
| 2015-09-30 | CA$23.55 Million ≈ $17.03 Million |
+30.82% |
| 2014-09-30 | CA$18.00 Million ≈ $13.02 Million |
+41.55% |
| 2013-09-30 | CA$12.72 Million ≈ $9.20 Million |
-5.87% |
| 2012-09-30 | CA$13.51 Million ≈ $9.77 Million |
-2.19% |
| 2011-09-30 | CA$13.81 Million ≈ $9.99 Million |
-3.50% |
| 2010-09-30 | CA$14.31 Million ≈ $10.35 Million |
+1.58% |
| 2009-09-30 | CA$14.09 Million ≈ $10.19 Million |
-3.53% |
| 2008-09-30 | CA$14.60 Million ≈ $10.56 Million |
+151.70% |
| 2007-09-30 | CA$5.80 Million ≈ $4.20 Million |
+46.61% |
| 2006-09-30 | CA$3.96 Million ≈ $2.86 Million |
+0.19% |
| 2005-09-30 | CA$3.95 Million ≈ $2.86 Million |
+17.04% |
| 2004-09-30 | CA$3.37 Million ≈ $2.44 Million |
+13.32% |
| 2003-09-30 | CA$2.98 Million ≈ $2.15 Million |
+9.43% |
| 2002-09-30 | CA$2.72 Million ≈ $1.97 Million |
-8.00% |
| 2001-09-30 | CA$2.96 Million ≈ $2.14 Million |
+1.77% |
| 2000-09-30 | CA$2.91 Million ≈ $2.10 Million |
+7.64% |
| 1999-09-30 | CA$2.70 Million ≈ $1.95 Million |
-67.86% |
| 1998-09-30 | CA$8.40 Million ≈ $6.08 Million |
-7.69% |
| 1997-09-30 | CA$9.10 Million ≈ $6.58 Million |
-- |
About Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures a wide range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays… Read more